CLINICAL_TRIALS
ClinicalTrials.gov record update
Comparing the Effects of Anakinra and Tocilizumab on Outcomes in Patients With New-Onset Refractory Status Epilepticus
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07281027
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:49.854139+00:00
- Published At
- 2025-12-15T00:00:00+00:00
- Record Updated At
- 2025-12-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["New Onset Refractory Status Epilepticus", "New-Onset Refractory Status Epilepticus", "Febrile Infection-Related Epilepsy Syndrome (FIRES)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-15"- protocolSection.identificationModule.nctId
"NCT07281027"- protocolSection.identificationModule.officialTitle
"Comparing the Effects of Anakinra and Tocilizumab on Outcomes in Patients With New-Onset Refractory Status Epilepticus"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.